
Press Release
Rayca Precision and ASAKE Partner on AI-Designed Therapeutics for Rare and Metabolic Diseases
AI-designed, physics-triaged therapeutics for rare and metabolic disease HELSINKI, Finland — SAN FRANCISCO, CA & ATHENS, OH — June 2, 2026 — Rayca Precision and ASAKE Biotechnology today